Gloria Pedot
Scientist at Matterhorn Biosciences- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Greater Zurich Area, CH
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Credentials
-
FACS cell sorting
Flow Cytometry facility, University of Zurich, SwitzerlandSep, 2017- Nov, 2024 -
LTK Module 1: Introductory Course in Laboratory Animal Science FELASA accredited
FEDERATION OF EUROPEAN LABORATORY ANIMAL SCIENCE ASSOCIATIONSAug, 2016- Nov, 2024
Experience
-
Matterhorn Biosciences
-
Switzerland
-
Biotechnology
-
1 - 100 Employee
-
Scientist
-
Feb 2023 - Present
Developing a new immunotherapy-based strategy to target cancer. Developing a new immunotherapy-based strategy to target cancer.
-
-
-
FimmCyte
-
Switzerland
-
Biotechnology
-
1 - 100 Employee
-
Scientist
-
Oct 2022 - Jan 2023
Contribute to the development of the first immune-based therapy through preclinical research for endometriosis. Contribute to the development of the first immune-based therapy through preclinical research for endometriosis.
-
-
-
University Children's Hospital Zurich
-
Zurich, Switzerland
-
Postdoctoral Researcher
-
Jan 2021 - Aug 2021
-
-
-
-
Ph.D. student
-
Jan 2016 - Dec 2020
-
-
-
Roche
-
Switzerland
-
Biotechnology Research
-
700 & Above Employee
-
Internship in Proteomics, pRED department
-
Apr 2014 - Jan 2015
-
-
-
University of Verona
-
Italy
-
Higher Education
-
700 & Above Employee
-
Internship in the department of Life and Reproduction Sciences
-
Oct 2011 - Jul 2012
-
-
Education
-
University of Zurich
Ph.D. in Cancer Biology -
Università di Trento
Master of Science in Cellular and Molecular Biotechnology -
Università degli Studi di Verona
Bachelor degree, Biotechnology
Community
You need to have a working account to view this content.
Click here to join now